Cynthia Sandor

Dr Cynthia Sandor

Group Leader

Developing new ways to detect and monitor Parkinson’s

Condition

Parkinson's disease

Biography

Dr Cynthia Sandor trained as a veterinary surgeon at the University of Liège and earned her PhD in statistical genetics, focusing on animal and human genetics under Professor Michel Georges. She then joined Harvard Medical School and the Broad Institute, contributing to genetic studies on autoimmune diseases. Cynthia later pursued postdoctoral research at the University of Oxford, evaluating induced pluripotent stem cell-derived neuronal models for Parkinson’s disease using omics data. She began her independent research career at Cardiff University after being awarded the Sêr Cymru II Fellowship and the UK DRI Emerging Leader award, where she worked under Professor Caleb Webber to explore disease heterogeneity in Parkinson’s disease. In 2024, Cynthia won the prestigious MRC Future Leader Fellowship, allowing her to carry out her work on the role of the adaptive immune system in Parkinson’s disease as a Group Leader. She also became a Safra Lecturer at the UK DRI at Imperial College, led by Professor Paul Matthews.

News

Key publications

Stem Cell Reports
Published
Reproducibility of Molecular Phenotypes after Long-Term Differentiation to Human iPSC-Derived Neurons: A Multi-Site Omics Study.
Authors
Viola Volpato, James Smith, Cynthia Sandor, Janina S Ried, Anna Baud, Adam Handel, Sarah E Newey, Frank Wessely, Moustafa Attar, Emma Whiteley, Satyan Chintawar, An Verheyen, Thomas Barta, Majlinda Lako, Lyle Armstrong, Caroline Muschet, Anna Artati, Carlo Cusulin, Klaus Christensen, Christoph Patsch, Eshita Sharma, Jerome Nicod, Philip Brownjohn, Victoria Stubbs, Wendy E Heywood, Paul Gissen, Roberta De Filippis, Katharina Janssen, Peter Reinhardt, Jerzy Adamski, Ines Royaux, Pieter J Peeters, Georg C Terstappen, Martin Graf, Frederick J Livesey, Colin J Akerman, Kevin Mills, Rory Bowden, George Nicholson, Caleb Webber, M Zameel Cader, Viktor Lakics
Reproducibility of Molecular Phenotypes after Long-Term Differentiation to Human iPSC-Derived Neurons: A Multi-Site Omics Study.
Hum Mol Genet
Published
Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson's disease.
Authors
Cynthia Sandor, Paul Robertson, Charmaine Lang, Andreas Heger, Heather Booth, Jane Vowles, Lorna Witty, Rory Bowden, Michele Hu, Sally A Cowley, Richard Wade-Martins, Caleb Webber
Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson's disease.

Sandor Lab

Explore the work of the Sandor Lab to develop new ways to detect and monitor Parkinson’s

 
Sandor Lab
A woman looks at her smart watch